{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T03:53:45Z","timestamp":1785210825587,"version":"3.55.0"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["FF-2013-28"],"award-info":[{"award-number":["FF-2013-28"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["CRC-TR 128"],"award-info":[{"award-number":["CRC-TR 128"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.bmc.2023.117350","type":"journal-article","created":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T02:13:09Z","timestamp":1685499189000},"page":"117350","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Influence of N-arylsulfonamido d-valine N-substituents on the selectivity and potency of matrix metalloproteinase inhibitors"],"prefix":"10.1016","volume":"90","author":[{"given":"Christian","family":"Paul Konken","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd","family":"Beutel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Schinor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"Gerwien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Korpos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Burmeister","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burkhard","family":"Riemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Sch\u00e4fers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lydia","family":"Sorokin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fcnter","family":"Haufe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2023.117350_b0005","unstructured":"Multiauthor Special issue \u201cMatrix Metalloproteinases\u201d. In Fridman F, Ed, Biochim Biophys Acta 2010;1803:3\u2013150."},{"key":"10.1016\/j.bmc.2023.117350_b0010","series-title":"Ed, Matrix metalloproteinase inhibitors","author":"Gupta","year":"2012"},{"key":"10.1016\/j.bmc.2023.117350_b0015","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1016\/j.jmb.2013.04.009","article-title":"Unraveling hidden regulatory sites in structurally homologous metalloproteases","volume":"425","author":"Udi","year":"2013","journal-title":"J Mol Biol"},{"key":"10.1016\/j.bmc.2023.117350_b0020","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/s41569-018-0022-z","article-title":"Assigning matrix metalloproteinase roles in ischaemic cardiac remodeling","volume":"15","author":"Lindsey","year":"2018","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.bmc.2023.117350_b0025","first-page":"904","article-title":"Is there new hope for therapeutic matrix metalloproteinase inhibitors?","volume":"13","author":"Vandenbroucke","year":"2014","journal-title":"Nat Rev"},{"key":"10.1016\/j.bmc.2023.117350_b0030","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1080\/17460441.2018.1398732","article-title":"Recent opportunities in matrix metalloproteinase inhibitor drug design for cancer","volume":"13","author":"Zong","year":"2018","journal-title":"Exp Opin Drug Disc"},{"key":"10.1016\/j.bmc.2023.117350_b0035","doi-asserted-by":"crossref","unstructured":"Fields GB. The rebirth of matrix metalloproteinase inhibitors: moving beyond the dogma. Cells 2019;8:984 (pp. 1-24).","DOI":"10.3390\/cells8090984"},{"key":"10.1016\/j.bmc.2023.117350_b0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112260","article-title":"Matrix metalloproteinase-9 (MMP-9) and its inhibitors in cancer: a minireview","volume":"194","author":"Mondal","year":"2020","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2023.117350_b0045","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1080\/13543776.2021.1881481","article-title":"Novel matrix metalloproteinase inhibitors: an updated patent review (2014\u20132020)","volume":"31","author":"Lenci","year":"2021","journal-title":"Exp Opin Ther Patents"},{"key":"10.1016\/j.bmc.2023.117350_b0050","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.matbio.2015.09.003","article-title":"Active site specificity profiling of the matrix metalloproteinase family: proteomic identification of 4300 cleavage sites by nine MMPs explored with structural and synthetic peptide cleavage analyses","volume":"49","author":"Eckhard","year":"2016","journal-title":"Matrix Biol"},{"key":"10.1016\/j.bmc.2023.117350_b0055","doi-asserted-by":"crossref","first-page":"10205","DOI":"10.1021\/jm500505f","article-title":"Targeting matrix metalloproteinases: exploring the dynamics of the S1\u2019 pocket in the design of selective, small molecule inhibitors","volume":"57","author":"Fabre","year":"2014","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2023.117350_b0060","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.2741\/4365","article-title":"MMP inhibitors: past, present and future","volume":"20","author":"Cathcart","year":"2015","journal-title":"Front Biosci"},{"key":"10.1016\/j.bmc.2023.117350_b0065","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.tips.2018.06.003","article-title":"MMP-responsive , smart\u2018 drug delivery and tumor targeting","volume":"39","author":"Yao","year":"2018","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.bmc.2023.117350_b0070","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.1021\/cr030448t","article-title":"Quantitative structure-activity relationship studies on Zinc-containing metalloproteinase inhibitors","volume":"107","author":"Gupta","year":"2007","journal-title":"Chem Rev"},{"key":"10.1016\/j.bmc.2023.117350_b0075","series-title":"Matrix metalloproteinase inhibitors","first-page":"137","article-title":"Hydroxamic acids as matrix metalloproteinase inhibitors","author":"Verma","year":"2012"},{"key":"10.1016\/j.bmc.2023.117350_b0080","first-page":"167","article-title":"Matrix metalloproteinase inhibitors for treatment of cancer","volume":"35","author":"Skiles","year":"2000","journal-title":"Ann Rep Med Chem"},{"key":"10.1016\/j.bmc.2023.117350_b0085","first-page":"554","article-title":"Remodeling MMPIs","volume":"13","author":"Hodgson","year":"1995","journal-title":"Biotechnology"},{"key":"10.1016\/j.bmc.2023.117350_b0090","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1021\/jm015531s","article-title":"Potent and selective carboxylic acid-based inhibitors of matrix metalloproteinases","volume":"44","author":"Pikul","year":"2001","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2023.117350_b0095","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.matbio.2017.12.012","article-title":"Matrix metalloproteinases and liver fibrosis (translational aspects)","volume":"68\u201369","author":"Roeb","year":"2018","journal-title":"Matrix Biol"},{"key":"10.1016\/j.bmc.2023.117350_b0100","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1016\/S0960-894X(03)00214-2","article-title":"Improved gelatinase A selectivity by novel zinc binding groups containing Galardin derivatives","volume":"13","author":"Aug\u00e9","year":"2003","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmc.2023.117350_b0105","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.2174\/0929867043364018","article-title":"The design, structure, and clinical update of small molecular weight matrix metalloproteinase inhibitors","volume":"11","author":"Skiles","year":"2004","journal-title":"Curr Med Chem."},{"key":"10.1016\/j.bmc.2023.117350_b0110","doi-asserted-by":"crossref","first-page":"10103","DOI":"10.1021\/bi9601969","article-title":"Understanding the P1\u2018 specificity of the matrix metalloproteinases: effects of S1\u2018 pocket mutations in matrilysin and stromelysin-1","volume":"35","author":"Welch","year":"1996","journal-title":"Biochemistry"},{"key":"10.1016\/j.bmc.2023.117350_b0115","first-page":"513","article-title":"Recent advances in design of matrix metalloproteinase inhibitors","volume":"7","author":"Matter","year":"2004","journal-title":"Curr Opin Drug Disc Dev"},{"key":"10.1016\/j.bmc.2023.117350_b0120","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1021\/jm9707582","article-title":"Highly selective and orally active inhibitors of type IV collagenase (MMP-9 and MMP-2): N-sulfonylamino acid derivatives","volume":"41","author":"Tamura","year":"1998","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2023.117350_b0125","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1021\/jm9903141","article-title":"Structure - activity relationships and pharmacokinetic analysis for a series of potent, systemically available biphenylsulfonamide matrix metalloproteinase inhibitors","volume":"43","author":"O\u2019Brien","year":"2000","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2023.117350_b0130","doi-asserted-by":"crossref","first-page":"339","DOI":"10.2174\/0929867053363243","article-title":"Matrix metalloproteinase inhibitors: a review on pharmacophore mapping and (Q)Sars results","volume":"12","author":"Kontogiorgis","year":"2005","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.bmc.2023.117350_b0135","series-title":"Matrix metalloproteinase inhibitors","first-page":"177","article-title":"Quantitative structure-activity relationship studies on sulfonamide-based MMP inhibitors","author":"Patil","year":"2012"},{"key":"10.1016\/j.bmc.2023.117350_b0140","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1016\/j.bmc.2019.03.043","article-title":"Identification of highly potent and selective MMP2 inhibitors addressing the S1\u2019 subsite with d-proline-based compounds","volume":"27","author":"Lenci","year":"2019","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2023.117350_b0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105155","article-title":"Biphenyl substituted lysine derivatives as recognition elements for the matrix metalloproteinases MMP-2 and MMP-9","volume":"115","author":"Kirchhain","year":"2021","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmc.2023.117350_b0150","series-title":"Frontiers of organofluorine chemistry","first-page":"447","article-title":"Fluorinated matrix metalloproteinase inhibitors (MMPIs) for potential application in therapy and diagnosis of diseases","author":"Hugenberg","year":"2020"},{"key":"10.1016\/j.bmc.2023.117350_b0155","series-title":"Bioorganic and medicinal chemistry of fluorine","author":"B\u00e9gu\u00e9","year":"2008"},{"key":"10.1016\/j.bmc.2023.117350_b0160","series-title":"Fluorine and health, molecular imaging, biomedical materials and pharmaceutical","year":"2008"},{"key":"10.1016\/j.bmc.2023.117350_b0165","series-title":"Fluorine in medicinal chemistry and chemical biology","year":"2009"},{"key":"10.1016\/j.bmc.2023.117350_b0170","series-title":"Fluorine in pharmaceutical and medicinal chemistry","year":"2012"},{"key":"10.1016\/j.bmc.2023.117350_b0175","series-title":"Organofluorine compounds in biology and medicine","author":"Reddy","year":"2015"},{"key":"10.1016\/j.bmc.2023.117350_b0180","series-title":"Fluorine in life sciences. Pharmaceuticals, medicinal diagnostics and agrochemicals","year":"2019"},{"key":"10.1016\/j.bmc.2023.117350_b0185","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ejmech.2014.03.064","article-title":"Study of the binding interaction between fluorinated matrix metalloproteinase inhibitors and Human Serum Albumin","volume":"79","author":"Digilio","year":"2014","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2023.117350_b0190","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaf8020","article-title":"Imaging matrix metalloproteinase activity in multiple sclerosis as a specific marker of leukocyte penetration of the blood-brain barrier","author":"Gerwien","year":"20168364152","journal-title":"Sci Trans Med"},{"key":"10.1016\/j.bmc.2023.117350_b0195","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1084\/jem.20051342","article-title":"Dystroglycan is selectively cleaved at the parenchymal basement membrane at sites of leukocyte extravasation in experimental autoimmune encephalomyelitis","volume":"203","author":"Agrawal","year":"2006","journal-title":"J Exp Med"},{"key":"#cr-split#-10.1016\/j.bmc.2023.117350_b0200.1","doi-asserted-by":"crossref","unstructured":"(a) Behrends M, Wagner S, Kopka K, Schober O, Sch\u00e4fers M, Kumbhar M, Waller M, Haufe G, New matrix metalloproteinase inhibitors based on \u03b3-fluorinated \u03b1-aminocarboxylic and \u03b1-aminohydroxamic acids. Bioorg Med Chem. 2015;23:3809-18","DOI":"10.1016\/j.bmc.2015.03.078"},{"key":"#cr-split#-10.1016\/j.bmc.2023.117350_b0200.2","doi-asserted-by":"crossref","unstructured":"(b) Beutel B, Daniliuc CG, Riemann B, Sch\u00e4fers M, Haufe G, Fluorinated matrix metalloproteinase inhibitors - Phosphonate based potential probes for positron emission tomography. Bioorg Med Chem. 2016;24:902-9","DOI":"10.1016\/j.bmc.2016.01.017"},{"key":"#cr-split#-10.1016\/j.bmc.2023.117350_b0200.3","doi-asserted-by":"crossref","unstructured":"(c) Hugenberg V, Behrends M, Wagner S, Hermann S, Sch\u00e4fers M, Kolb H-C, Szardenings K, Walsh JC, Gomez LF, Kopka K, Haufe G, Synthesis, radiosynthesis, in vitro and first in vivo evaluation of new matrix metalloproteinase inhibitor based on \u03b3-fluorinated \u03b1-sulfonylaminohydroxamic acid. EJNMMI Radiopharm Chem. 2018;3(10):1-20","DOI":"10.1186\/s41181-018-0045-0"},{"key":"#cr-split#-10.1016\/j.bmc.2023.117350_b0200.4","doi-asserted-by":"crossref","unstructured":"(d) Beutel B, Song J, Konken CP, Korpos E, Schinor B, Gerwien H, Vidyadharan R, Burmeister M, Li L, Haufe G, Sorokin L, New in vivo compatible matrix metalloproteinase (MMP)-2 and MMP-9 inhibitors. Bioconj Chem. 2018;29:3715-25.","DOI":"10.1021\/acs.bioconjchem.8b00618"},{"key":"10.1016\/j.bmc.2023.117350_b0205","unstructured":"Yoshioka T, Maekawa R, Watanabe F, Oxadiazole derivatives having anticancer effects, US 6.720.343 B2 (Appl. 16.04.2001); EP 1.277.744 A1 (Appl. 16.04.2001)."},{"key":"10.1016\/j.bmc.2023.117350_b0210","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1002\/ejoc.201001174","article-title":"Lewis-acid-mediated domino reactions of bis(diacetoxymethyl)-substituted arenes and heteroarenes","author":"Clement","year":"2011","journal-title":"Eur J Org Chem"},{"key":"10.1016\/j.bmc.2023.117350_b0215","doi-asserted-by":"crossref","first-page":"4113","DOI":"10.1021\/ja01524a080","article-title":"A new and selective method of oxidation. The conversion of alkyl halides and alkyl tosylates to aldehydes","volume":"81","author":"Kornblum","year":"1959","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.bmc.2023.117350_b0220","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1021\/jo00893a007","article-title":"New fluorinating reagents. Dialkylaminosulfur fluorides","volume":"40","author":"Middleton","year":"1975","journal-title":"J Org Chem"},{"key":"10.1016\/j.bmc.2023.117350_b0225","doi-asserted-by":"crossref","first-page":"7048","DOI":"10.1021\/jo990566+","article-title":"Bis (2-methoxyethyl) aminosulfur trifluoride: a new broad-spectrum deoxofluorinating agent with enhanced thermal stability","volume":"64","author":"Lal","year":"1999","journal-title":"J Org Chem"},{"key":"10.1016\/j.bmc.2023.117350_b0230","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1055\/s-1973-22302","article-title":"Application of dialkylaminosulfur trifluorides in the synthesis of fluoroorganic compounds","author":"Markovskij","year":"1973","journal-title":"Synthesis"},{"key":"10.1016\/j.bmc.2023.117350_b0235","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.1021\/ol300977f","article-title":"Palladium-catalyzed substitution and cross-coupling of benzylic fluorides","volume":"14","author":"Blessley","year":"2012","journal-title":"Org Lett"},{"key":"10.1016\/j.bmc.2023.117350_b0240","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1021\/jm201142w","article-title":"A new generation of radiofluorinated pyrimidine-2, 4, 6-triones as MMP-targeted radiotracers for positron emission tomography","volume":"55","author":"Schrigten","year":"2012","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2023.117350_b0245","doi-asserted-by":"crossref","first-page":"22086","DOI":"10.1074\/jbc.272.35.22086","article-title":"Mutational study of the amino-terminal domain of Human Tissue Inhibitor of metalloproteinases 1 (TIMP-1) locates an inhibitory region for matrix metalloproteinases","volume":"272","author":"Huang","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmc.2023.117350_b0250","first-page":"29","article-title":"New facets of matrix metalloproteinases MMP-2 and MMP-9 as cell surface transducers. Outside-in signaling and relationship to tumor progression","author":"Bauvois","year":"1825","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.bmc.2023.117350_b0255","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.celrep.2015.01.037","article-title":"Focal MMP-2 and MMP-9 activity at the blood-brain barrier promotes chemokine-induced leukocyte migration","volume":"10","author":"Song","year":"2015","journal-title":"Cell Rep"},{"key":"10.1016\/j.bmc.2023.117350_b0260","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.matbio.2017.11.007","article-title":"The gelatinases, MMP-2 and MMP-9, as fine tuners of neuroinflammatory processes","volume":"75\u201376","author":"Hannocks","year":"2019","journal-title":"Matrix Biol"},{"key":"10.1016\/j.bmc.2023.117350_b0265","series-title":"Matrix metalloproteinase inhibitors","first-page":"57","article-title":"The Gelatinases and their inhibitors: the structure-activity relationships","author":"Swarnaker","year":"2012"},{"key":"10.1016\/j.bmc.2023.117350_b0270","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/cbic.201300698","article-title":"An integrated computational and experimental approach to gaining selectivity for MMP-2 within the gelatinase subfamily","volume":"15","author":"Fabre","year":"2014","journal-title":"Chembiochem"},{"key":"10.1016\/j.bmc.2023.117350_b0275","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.bbamcr.2009.08.006","article-title":"To bind zinc or not to bind zinc: an examination of innovative approaches to improved metalloproteinase inhibitors","volume":"1803","author":"Jacobson","year":"2010","journal-title":"Biochim Biophys Acta"},{"key":"#cr-split#-10.1016\/j.bmc.2023.117350_b0280.1","doi-asserted-by":"crossref","unstructured":"Tochowicz A, Maskos K, Huber R, Oltenfreiter R, Dive V, Yiotakis A, Zanda M, Bode W, Goettig P, Crystal structures of MMP-9 complexes with five inhibitors: contribution of the flexible Arg424 side-chain to selectivity. J Mol Biol 2007;371:989-1006","DOI":"10.1016\/j.jmb.2007.05.068"},{"key":"#cr-split#-10.1016\/j.bmc.2023.117350_b0280.2","unstructured":"see the corrigendum J Mol Biol 2009;388:917-8."},{"key":"10.1016\/j.bmc.2023.117350_b0285","doi-asserted-by":"crossref","first-page":"14070","DOI":"10.1021\/ja806090v","article-title":"From the X-ray compact structure to the elongated form of the full-length MMP-2 enzyme in solution: a molecular dynamics study","volume":"130","author":"Diaz","year":"2008","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.bmc.2023.117350_b0290","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1021\/jm050787+","article-title":"Structural insight into the stereoselective inhibition of MMP-8 by enantiomeric sulfonamide phosphonates","volume":"49","author":"Pochetti","year":"2006","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2023.117350_b0295","unstructured":"MacPherson LJ, Parker DT, EP 606.046 A1; 1994."},{"key":"10.1016\/j.bmc.2023.117350_b0300","doi-asserted-by":"crossref","first-page":"6858","DOI":"10.1021\/jm4006753","article-title":"Inverse 1, 2, 3-triazole-1-yl-ethyl substituted hydroxamates as highly potent matrix metalloproteinase inhibitors:(radio) synthesis, in vitro and first in vivo evaluation","volume":"56","author":"Hugenberg","year":"2013","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2023.117350_b0305","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1021\/bc700409j","article-title":"Synthesis and evaluation of a novel fluorescent photoprobe for imaging matrix metalloproteinases","volume":"19","author":"Faust","year":"2008","journal-title":"Bioconj. Chem"}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089623001980?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089623001980?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T08:30:28Z","timestamp":1778574628000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089623001980"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":65,"alternative-id":["S0968089623001980"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2023.117350","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Influence of N-arylsulfonamido d-valine N-substituents on the selectivity and potency of matrix metalloproteinase inhibitors","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2023.117350","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"117350"}}